Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tauro-β-muricholic Acid sodium is a endogenous metabolite, is a competitive and reversible antagonist of farnesoid X receptor (FXR)(IC50 of 40 μM).
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
500 μg | 約 35 days | ¥ 41,500 |
1 mg | 約 35 days | ¥ 77,500 |
5 mg | 約 35 days | ¥ 243,500 |
説明 | Tauro-β-muricholic Acid sodium is a endogenous metabolite, is a competitive and reversible antagonist of farnesoid X receptor (FXR)(IC50 of 40 μM). |
ターゲット&IC50 | FXR:40 μM |
別名 | T-βMCA sodium |
分子量 | 538.7 |
分子式 | C26H45NNaO7S |
CAS No. | 145022-92-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Tauro-β-muricholic acid sodium 145022-92-0 Metabolism FXR T-betaMCA sodium Tauro-b-muricholic acid sodium T-βMCA sodium T-bMCA sodium Tauroβmuricholic acid sodium Tauro β muricholic acid sodium Tauro-beta-muricholic acid sodium Inhibitor inhibitor inhibit